Arcellx, Inc. (ACLX)
74.08
+4.52
(+6.50%)
USD |
NASDAQ |
Dec 08, 16:00
74.51
+0.43
(+0.58%)
After-Hours: 05:59
Arcellx Total Liabilities (Quarterly): 215.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.08B |
| Geron Corp. | 318.68M |
| Daré Bioscience, Inc. | 27.89M |
| Cartesian Therapeutics, Inc. | 408.52M |
| Cabaletta Bio, Inc. | 50.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 655.92M |
| Shareholders Equity (Quarterly) | 440.78M |
| Debt to Equity Ratio | 0.1175 |
| Current Ratio | 3.987 |
| Net Debt Paydown Yield | 0.09% |